CN Patent
CN112812128B — 作为alk和ros调节剂的大环化合物
Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2024-04-02 · 2y expired
What this patent protects
本发明属于药物化学领域,涉及作为ALK和ROS调节剂的大环化合物,具体而言,涉及式I化合物或其药学上可接受的盐、制备方法、含有该化合物的药物组合物,以及其在治疗癌症中的用途。
USPTO Abstract
本发明属于药物化学领域,涉及作为ALK和ROS调节剂的大环化合物,具体而言,涉及式I化合物或其药学上可接受的盐、制备方法、含有该化合物的药物组合物,以及其在治疗癌症中的用途。
Drugs covered by this patent
- Lorbrena (lorlatinib) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.